Erik Jakobsen

17.8k citations
151 papers · 4.3k indexed · 1 hit paper · h-index 30
Topics
Lung Cancer Treatments and Mutations (45 papers)Lung Cancer Diagnosis and Treatment (41 papers)HER2/EGFR in Cancer Research (33 papers)
Journals
Nature MedicineJournal of Clinical OncologySHILAP Revista de lepidopterología

In The Last Decade

Erik Jakobsen

143 papers receiving 4.2k citations

Hit Papers

Five Years of Letrozole Compared With Tamoxifen As Initia...20072026201320192007200400600

Peers

Erik Jakobsen
Comparison fields: 5 of 132
  • Oncology 2.3k
  • Pulmonary and Respiratory Medicine 1.6k
  • Cancer Research 1.1k
  • Genetics 676
  • Molecular Biology 657
Replace David A. Kooby with:
David A. Kooby United States
Richard Caplan United States
Andrea Frilling Germany
Bernard H. Bochner United States
Mitchell C. Posner United States
Bryan M. Clary United States
Leah Ben‐Porat United States
Andrew C. Chang United States
Richard J. Gray United States
Jing Jiang China
Erik Jakobsen relative to David A. Kooby United States David A. Kooby's profile →
Citations per field
00.5×1.5×
David A. Kooby · 1×
Citations per year

Countries citing papers authored by Erik Jakobsen

Since Specialization
Citations

This map shows the geographic impact of Erik Jakobsen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Erik Jakobsen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Erik Jakobsen more than expected).

Fields of papers citing papers by Erik Jakobsen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Erik Jakobsen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Erik Jakobsen. The network helps show where Erik Jakobsen may publish in the future.

Co-authorship network of co-authors of Erik Jakobsen

This figure shows the co-authorship network connecting the top 25 collaborators of Erik Jakobsen. A scholar is included among the top collaborators of Erik Jakobsen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Erik Jakobsen. Erik Jakobsen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 2
2 7
3 1
4 4
5 3
6 12
7 12
8 2
9 21
10 44
11 4
12 13
13 29
14 153
15 13
16 97
17
Prognostic impact of VEGFA germline polymorphisms in patients with HER2-positive primary breast cancer.
10
18
Dansk Lunge Cancer Register
0
19 20
20 8

About Erik Jakobsen

Erik Jakobsen is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Cancer Research, having authored 151 papers that have together received 4.3k indexed citations. Recurring topics across this work include Lung Cancer Treatments and Mutations (45 papers), Lung Cancer Diagnosis and Treatment (41 papers) and HER2/EGFR in Cancer Research (33 papers). The work is most often cited by research in Oncology (2.3k citations), Cancer Research (1.1k citations) and Pulmonary and Respiratory Medicine (1.6k citations). Erik Jakobsen has collaborated with scholars based in Denmark, United Kingdom and United States. Frequent co-authors include Anders Green, Lars Stenbygaard, Torben Riis Rasmussen, Henrik Møller, Maria Iachina, Maj‐Britt Jensen, Dorte Nielsen, Anders Jakobsen, Søren Cold and Marianne Ewertz. Their work appears in journals such as Nature Medicine, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026